✦ LIBER ✦

Effect of HMG-CoA reductase inhibitors on plasma polyunsaturated fatty acid concentrations in patients with hyperlipidemia

✍ Scribed by N. Nakamura; T. Hamazaki; H. Jokaji; S. Minami; M. Kobayashi

Publisher: Springer
Year: 1998
Tongue: English
Weight: 341 KB
Volume: 28
Category: Article
ISSN: 0940-5437
DOI: 10.1007/s005990050043

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Joint effects of HMG-CoA reductase inhib

Joint effects of HMG-CoA reductase inhibitors and eicosapentaenoic acids on serum lipid profile and plasma fatty acid concentrations in patients with hyperlipidemia

✍ N. Nakamura; T. Hamazaki; M. Ohta; K. Okuda; M. Urakaze; S. Sawazaki; K. Yamazak 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 394 KB

Modification of phospholipids fatty acid

Modification of phospholipids fatty acid composition in reuber H35 hepatoma cells: Effect on HMG-CoA reductase activity

✍ M. Carmen García-Pelayo; Eduardo García-Peregrín; Marina Martínez-Cayuela 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 116 KB

## Abstract There is controversy about the effect of saturated and polyunsaturated fats on 3‐hydroxy‐3‐methylglutaryl‐CoA (HMG‐CoA) reductase, the main regulatory enzyme of cholesterogenic pathway. Results from dietary studies are difficult to interpret because diets normally contain a mixture of f

Effect of pioglitazone on urinary liver-

Effect of pioglitazone on urinary liver-type fatty acid-binding protein concentrations in diabetes patients with microalbuminuria

✍ Tsukasa Nakamura; Takeshi Sugaya; Yasuhiro Kawagoe; Yoshihiko Ueda; Hikaru Koide 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB

Effects of cilostazol on serum lipid con

Effects of cilostazol on serum lipid concentrations and plasma fatty acid composition in type 2 diabetic patients with peripheral vascular disease

✍ N. Nakamura; T. Hamazaki; H. Johkaji; S. Minami; K. Yamazaki; A. Satoh; S. Sawaz 📂 Article 📅 2003 🏛 Springer 🌐 English ⚖ 53 KB

Meta-analysis of the effects ofn-3 polyu

Meta-analysis of the effects ofn-3 polyunsaturated fatty acids on lipoproteins and other emerging lipid cardiovascular risk markers in patients with type 2 diabetes

✍ J. Hartweg; A. J. Farmer; R. Perera; R. R. Holman; H. A. W. Neil 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 277 KB